Phenotyping and Biospecimen Core
Phenotyping and Biospecimen Core
批准号:
10689334
负责人:
Stacy Andersen
金额:
$146.52万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-30 至 2026-08-31
关键词:
AffectAgeAlzheimer&aposs DiseaseAlzheimer’s disease biomarkerAmyloid beta-42AnatomyAreaAutopsyBiologicalBiological AssayBiological MarkersBlood specimenBostonBrainCOVID-19CentenarianClinical DataCognitiveConsensusDataData CollectionDedicationsDementiaDiagnosisDisease MarkerElderlyEligibility DeterminationEnrollmentEnsureFamiliarityFastingFundingFutureGene ExpressionGeneticGenetic TranscriptionImpaired cognitionImpairmentInvestigationKnowledge PortalLeadLinkLongevityLos AngelesMeasuresMissionModelingMolecularNeurocognitiveNeuropsychological TestsNeuropsychologyNew York CityOutcomeParticipantPathologicPatient RecruitmentsPhenotypePlasmaRNAResearch PersonnelResistanceResourcesSamplingScanningSecureSpousesStatistical Data InterpretationSystemTissuesWorkbiobankcognitive functioncytokinedata de-identificationdata managementdata sharingexomeexperienceinnovationneuroimagingneuropathologyoffspringparticipant enrollmentphenotypic dataprotective factorsrecruitresiliencesuccesssymposiumtooltranscriptomicstranslational potentialvirtual
中文摘要
表型鉴定和生物学家(P&B)核心的主要任务是利用NIA资助的两名百岁老人
通过筛选研究参与者来确定百岁认知超级老年人、后代和
参加RADCO研究的子女配偶,延长他们的表型,穿上年度制服
神经心理测试,阿尔茨海默病(AD)的血浆生物标志物,以及促进和促进
自愿受试者的神经影像和死后神经病理学研究。P&B Core的
其六个目标的成功实施对于RADCO对百岁老人及其后代的调查至关重要
认知复原力和对认知障碍和AD的抵抗的模型。这6个具体目标是:
具体目标1.建立认知超级老年人(n=496,年龄100-110岁)、子代(n=600)和子代
配偶(n=120)样本,包括基线神经心理评估、其他表型数据、血样、
以及由NIA资助的两项正在进行的百岁老人研究提供的遗传和生物标记数据。具体目标2.执行
年度新冠肺炎安全虚拟神经认知评估和其他统一的表型数据收集
与劳工组织的研究和LCCP措施相一致。此外,为了提高神经认知评估的准确性,
召开跨学科专家诊断共识会议。具体目标3.聘用红帽,
管理和执行质量控制,并轻松但安全地使用由收集和生成的所有数据
RADCO核心和项目,包括神经心理学、神经成像、神经病理表型和
生物标志物和转录组数据。具体目标4.从劳工组织LCCP获得研究报告,然后
纵向采集血样(百岁老人每年采集一次,后代及其配偶每隔一年采集一次)
来自RADCO参与者的数据,供两个项目使用。将生物储存库中的样本作为可共享的
资源。具体目标5.通过招募RADCO参与者来支持RADCO神经成像核心的目标
局部神经成像和将扫描数据与临床数据相关联。具体目标6.为未来招募RADCO参与者
脑捐献,确保尸检顺利进行,并将临床数据与解剖、病理和
由P&B神经病理学工作产生的分子数据。这些数据将通知具有弹性和抵抗力的
在项目1中描绘的表型。脑区特定组织将被提供用于RNA表达研究
项目2.
英文摘要
The Phenotyping and Biospecimen (P&B) Core's primary mission is to leverage two NIA-funded centenarian
studies by sifting through their study participants in identifying centenarian cognitive superagers, offspring and
offspring spouses for enrollment in the RADCO study, extending their phenotyping with annual uniform
neuropsychological testing, plasma biomarkers of Alzheimer's disease (AD), and facilitating and facilitating
neuroimaging and post-mortem neuropathological studies among willing participants. The P&B Core's
successful conduct of its six aims is critical to RADCO's investigation of centenarians and their offspring as
models of cognitive resilience and resistance to cognitive impairment and AD. Those 6 Specific Aims are:
Specific Aim 1. Establish a cognitive superagers (n=496, ages 100-110 years), offspring (n=600), and offspring
spouses (n=120) sample with baseline neuropsychological assessments, other phenotypic data, blood samples,
and genetic and biomarker data provided by 2 ongoing NIA-funded centenarian studies. Specific Aim 2. Perform
annual Covid-19-safe virtual neurocognitive assessments and other phenotypic data collection that are uniform
with the ILO study and LCCP measures. Also, to enhance accuracy of the neurocognitive assessments by
performing interdisciplinary expert diagnoses consensus conferences. Specific Aim 3. Employing REDCap,
manage and perform QC, and make easily but securely available all of the data collected and generated by the
RADCO Cores and Projects, including the neuropsychological, neuroimaging, neuropathologic phenotype and
biomarker and transcriptomic data. Specific Aim 4. To receive from the ILO+LCCP studies and then
longitudinally collect blood samples (centenarians annually, offspring and offspring spouses every other year)
from RADCO participants for use by the two projects. To maintain samples in a biorepository as a sharable
resource. Specific Aim 5. Support the RADCO Neuroimaging Core's aims by recruiting RADCO participants for
local neuroimaging and linking scan data to clinical data. Specific Aim 6. Recruit RADCO participants for future
brain donation, ensure that autopsies proceed smoothly, and link clinical data to anatomic, pathologic and
molecular data generated by the P&B neuropathology efforts. These data will inform the resilient and resistant
phenotypes delineated in Project 1. Brain area-specific tissues will be provided for RNA expression studies in
Project 2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
-
批准号:10713947
-
项目类别:
-
资助金额:$45.83万
-
财政年份:2021
-
负责人:Stacy Andersen
-
依托单位:
Phenotyping and Biospecimen Core
-
批准号:10713948
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2021
-
负责人:Stacy Andersen
-
依托单位:
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
-
批准号:10532568
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2021
-
负责人:Stacy Andersen
-
依托单位:
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
-
批准号:10276389
-
项目类别:
-
资助金额:$427.9万
-
财政年份:2021
-
负责人:Stacy Andersen
-
依托单位:
Phenotyping and Biospecimen Core
-
批准号:10276393
-
项目类别:
-
资助金额:$149.07万
-
财政年份:2021
-
负责人:Stacy Andersen
-
依托单位:
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
-
批准号:10689330
-
项目类别:
-
资助金额:$434.51万
-
财政年份:2021
-
负责人:Stacy Andersen
-
依托单位:
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia
-
批准号:10190755
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2018
-
负责人:Stacy Andersen
-
依托单位:
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia
-
批准号:10440381
-
项目类别:
-
资助金额:$11.91万
-
财政年份:2018
-
负责人:Stacy Andersen
-
依托单位:
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia
-
批准号:9598551
-
项目类别:
-
资助金额:$11.93万
-
财政年份:2018
-
负责人:Stacy Andersen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: